244.60BMarket Cap260.12P/E (TTM)
0.000High0.000Low0Volume0.000Open22.370Pre Close0.00Turnover0.00%Turnover Ratio248.56P/E (Static)10.93BShares22.72052wk High13.21P/B244.60BFloat Cap11.41352wk Low0.80Dividend TTM10.93BShs Float22.720Historical High3.57%Div YieldTTM0.00%Amplitude-0.275Historical Low--Avg Price1Lot Size
CHINA GALAXY SECUR Stock Forum
In an interview with The Business Times, CGS-CIMB’s group head of investment management Ademola Olopade said China’s small-cap sector showcases “high-growth stocks” – or the future Tencent or Alibaba stocks – in sectors such as pharma...
The CGS Fullgoal CSI 1000 ETF mirrors the China stock market’s small-cap index – the CSI 1000 Index.
The fund, which offers dual currency trading in US dollars and Singapore dollars, comprises 1,000 China-listed companies that have a market capitalisation of less than 20 billion yuan (S$3....
Price target:
$UOB Kay Hian (U10.SG)$ UOB Kay Hian ‘buy’ US$94.34
$Citigroup (C.US)$ Citi Research ‘buy’ $110
$CGS (06881.HK)$ CGS-CIMB Research ‘add’ US$105
CGS-CIMB has raised its target price on Sea to US$105 from US$85, implying a potential upside of 31.3 per cent. Its new target price of US$105 is based on a higher e-commerce price-to-sales multiple of four times, compared with 2.9 times previously. CGS-CIMB also reiterated its “add” call on the stock.
With the group turning profitable in Q4, Sea is now better placed to purs...
Given how DBS is currently trading at 1.3 times FY2023 price-to-book value (P/BV) versus its peers’ ratio of about one time, and signs of a potential slowdown in the Federal Reserve’s pace of its rate hikes have led CGS-CIMB to downgrade its sector call to “neutral” from “overweight”.
CGS-CIMB said DBS could be the most suscepti...
Based on the overall version number issuance approval this year, with the normalization of version number approval, the manufacturer's performance is expected to be significantly restored. At present, the industry as a whole is at the bottom of the valuation, and the head game comp...
No comment yet